Yacht Bio-Tech Co., Ltd. is a R&D and process improvement company for bio-medicines. We are mainly engaged in new drugs research, process improvement, drug structural analysis, products quality, and establishing the standards of products. Our fields refer to anti-tumor, anti-infective, cardiovascular, and immune system drugs. Also in the field of technical research and product development, we are able to enlarge the production from laboratory scale to pilot plant scale. By now, we provide optimum technical service from laboratory production/scale to pilot plant scale. In same cases, we even provide the small commercial scale. Our main focus is on the field of developing microbe and synthetic chemicals, doing innovative research in partial synthesis of antibiotic new drugs, products and technics, and also doing research in sreening new drugs from microbe. We combine genetic engineering technics with tranditional technics, which is used for breeding strains in antibiotics from microbe
Year Established: 2004
Total Assets(USD): 3,000,000 to 3,999,999
Total Number of Staff: 80 to 89
Main Competitive Advantages:
Business Type: Manufacturer
Annual Turnover(USD) : 6,000,000 to 6,999,999
Main Sales Markets : North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Subscribe to the latest newsletter of Virtual Expo Connect